The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Publications hub
Find our publications, laboratory reports, meeting minutes and statements, and scheduling decisions.
We’re still confirming the best location for some of our content. Can't find what you’re looking for? You can also:
-
search our Resources
-
use the site search bar in the top right of this screen for more results.
Loading...
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- Advisory bodies and committees (359)
- Scheduling (national classification system) (155)
- Prescription medicines (34)
- Advertising (25)
- In Vitro Diagnostic medical devices (IVDs) (24)
- Medicine safety (22)
- Therapeutic goods regulation (20)
- Medical devices safety (13)
- Manufacturing (11)
- Safety (11)
- Complementary medicines (9)
- Non-prescription medicines (9)
- Over the counter (OTC) medicines (8)
- Regulatory compliance (8)
- COVID-19 vaccines (7)
- Listed medicines (7)
- COVID-19 (6)
- Medicinal cannabis hub (6)
- Registered complementary medicines (6)
- Assessed listed medicines (5)
- Shortages (4)
- Alert/Advisory (3)
- Fees and payments (3)
- Legislation (3)
- Clinical trials (2)
- Compliance and enforcement hub (2)
- Import and export (2)
- Sunscreens (2)
- Artificial Intelligence (AI) (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biological medicines (1)
- Breast implant hub (1)
- Cosmetics (1)
- Disinfectants/Sterilants (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Pharmacovigilance (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
708 result(s) found, displaying 301 to 325
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
-
PublicationsThe July-December 2020 Half Yearly Performance Statistics Report is now available
-
Meeting statementsA meeting of the Therapeutic Goods Advertising Consultative Committee was held on 31 March 2021
-
PublicationsThe Australian Government has accepted all 22 recommendations
-
PublicationsGuidance for procurement areas in hospitals, aged care residential facilities and other facilities.
-
-
Meeting statementsDetails about meeting 1 for the medical device reform consumer working group held in 2019.
-
Meeting statementsDetails about meeting 2 for the medical device reform consumer working group held in 2020.
-
Meeting statementsDetails about meeting 3 for the medical device reform consumer working group held in 2020.
-
Meeting statementsDetails about meeting 4 for the medical device reform consumer working group held in 2020.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
-
Scheduling submissionsPublic submissions made in response to the proposed amendments to the Poisons Standard published on 26 August 2020
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 4 March 2021.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 10 November 2020
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Scheduling submissionsPublic submissions made in response to the interim decisions published on 9 September 2020
-
PublicationsTargets have been met for the measures under the six KPIs
-
Scheduling submissionsPublic submissions made in response to the interim decision on nicotine scheduling published on 23 September 2020
-
Scheduling decisions (final)Public notice of the delegate's final decision to amend the current Poisons Standard in relation to nicotine
-
PublicationsProposal to prevent the uptake of nicotine containing e-cigarettes by ever users (adolescents and young adults), to support smoking cessation and to reduce nicotine poisonings of children
-
Scheduling decisions (final)Public notice of the delegate's final decision to amend the Poisons Standard in relation to cannabidiol (private application and delegate initiated) - Joint ACMS-ACCS #25 and #26 (June and November 2020).